Introduction
Discoid lupus erythematosus (DLE) is uncommon in the first decade of life. It has been described as part of systemic lupus erythematosus (SLE) or in isolation in adults 1 . We report a case of severe haemolytic anaemia with discoid lesions that gave a clue to diagnosis and management.
Case report A 10 year old girl presented with headache, fever, weakness and skin lesions over face for 1 month. Child had been transfused with blood earlier for severe anaemia. Examination revealed severe pallor, jaundice, hepatosplenomegaly and congestive heart failure. There were two discoid, scaly macules with irregular margins and peripheral hyperpigmentation in the left side of the face below lower eyelid ( Figure A Criteria for diagnosing SLE. Child was treated with pulsed methyl prednisone (30mg/kg) for five days followed by prednisone 1mg/kg/day for 4 weeks tapering over next 4 weeks. Congestive heart failure was managed with furosemide and enalapril. Discoid lesions were treated with topical triamcinolone acetonide 0.1% cream and sun screening. Lesions responded to treatment over 4 weeks ( Figure B) . Haemoglobin level improved and child was asymptomatic at latest follow up.
Discussion
Discoid lesions without other manifestations may be mistaken for pityriasis alba and pityriasis versicolor. It should be confirmed by skin biopsy and immunological tests. Revised College of Rheumatology criteria for the classification of SLE should be applied to differentiate this from SLE 2 .
The median age at diagnosis of DLE is 30 years 1 . SLE appears in 17-30% presenting as only discoid lesions and discoid lesions appear in 8-28% of SLE 3, 4, 5 . When confined to head and neck DLE is less likely to progress to SLE (5%) than when it presents below the neck (20%) 5, 7 . Reported median age at diagnosis of SLE with DLE is 41.5 years 1 . Haemolysis is commoner with discoid lesions 1 and in paediatric SLE. SLE patients with discoid lupus are less likely to present end-stage renal disease 8 . Our case did not fulfil diagnostic criteria for SLE.
Treatment of DLE includes topical steroids, tacrolimus 0.1% ointment, pimecrolimus 1% cream and sunscreening 9 . Tacrolimus 0.1% ointment and pimecrolimus 1% cream are safe and effective in resistant cases of DLE or facial DLE where topical steroid use heightens risk of thinning and telangiectasia 8 . Persistent, severe lesions could be treated with full thickness skin graft. Recurrence with skin grafting is treated with topical steroid 10 . The presence of DLE should be searched for in all autoimmune haemolytic anaemia regardless of age.
